Evidence map›Paper›PMID 41772910›Full record

ReviewPediatric pulmonology2026

A Narrative Review of Gene-Environment Interactions in Pediatric Pulmonology.

Jelte Kelchtermans

Abstract readReview
In one paragraph

Review in Pediatric pulmonology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jelte KelchtermansChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-9186-7547

Funding

Critical Life Event supplement to 'Air pollution sensitivity in pediatric asthma'K08HL173625 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI Jelte Kelchtermans · 2025 to 2026
$317k
NHLBI NIH HHS K08 HL173625NHLBI NIH HHS K08HL173625
6 · The paper itself

Abstract

Genetic and environmental factors are known to shape the onset, course, and outcomes of pediatric lung disease, yet interactions between these variables are rarely considered in clinical practice. Gene-environment (GxE) interactions occur when the combined effect of a genetic variant and an environmental exposure differs from what would be expected from combining the effect of either variable alone. Considering these interactions may reveal subgroups at heightened risk, explain apparent inconsistencies across studies, and highlight opportunities for targeted intervention. In this narrative review, we outline the conceptual basis of GxE interactions, including the importance of scale, centering, and timing. We summarize their implications and provide a high-level overview of available analytic strategies. We then examine disease-specific findings in asthma, cystic fibrosis, and bronchopulmonary dysplasia, highlighting how GxE processes can shape lung health from early life into adulthood and may contribute to chronic obstructive pulmonary disease risk. Across the asthma and cystic fibrosis examples presented here, commonly reported interactions involve genes related to host defense and oxidative stress biology, with effects that appear sensitive to exposure timing and developmental context. We conclude by identifying near-term priorities for improving rigor, mechanistic integration, and translation. Together, these insights frame pediatric lung disease within a life-course GxE model, emphasizing that genetic susceptibility and environmental risk should be considered jointly to improve outcomes.

Indexed as

Gene-Environment InteractionLung DiseasesAsthmaBronchopulmonary DysplasiaChildCystic FibrosisEnvironmental ExposureGenetic Predisposition to DiseaseHumansenvironmental exposuresgenetic susceptibilitypediatric lung diseasepolygenic risk

Identifiers

PMID41772910
PMCPMC12954361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.